Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.

Honkanen H, Oikarinen S, Nurminen N, Laitinen OH, Huhtala H, Lehtonen J, Ruokoranta T, Hankaniemi MM, Lecouturier V, Almond JW, Tauriainen S, Simell O, Ilonen J, Veijola R, Viskari H, Knip M, Hyöty H.

Diabetologia. 2017 Mar;60(3):424-431. doi: 10.1007/s00125-016-4177-z. Epub 2017 Jan 9.

PMID:
28070615
2.

Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.

Glanville N, McLean GR, Guy B, Lecouturier V, Berry C, Girerd Y, Gregoire C, Walton RP, Pearson RM, Kebadze T, Burdin N, Bartlett NW, Almond JW, Johnston SL.

PLoS Pathog. 2013;9(9):e1003669. doi: 10.1371/journal.ppat.1003669. Epub 2013 Sep 26.

3.

Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes.

Laitinen OH, Honkanen H, Pakkanen O, Oikarinen S, Hankaniemi MM, Huhtala H, Ruokoranta T, Lecouturier V, André P, Harju R, Virtanen SM, Lehtonen J, Almond JW, Simell T, Simell O, Ilonen J, Veijola R, Knip M, Hyöty H.

Diabetes. 2014 Feb;63(2):446-55. doi: 10.2337/db13-0619. Epub 2013 Aug 23.

4.

Vaccine production, distribution, access, and uptake.

Smith J, Lipsitch M, Almond JW.

Lancet. 2011 Jul 30;378(9789):428-38. doi: 10.1016/S0140-6736(11)60478-9. Epub 2011 Jun 12.

5.

Picornaviruses.

Yin-Murphy M, Almond JW.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 53.

6.

Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation.

Bartlett NW, Walton RP, Edwards MR, Aniscenko J, Caramori G, Zhu J, Glanville N, Choy KJ, Jourdan P, Burnet J, Tuthill TJ, Pedrick MS, Hurle MJ, Plumpton C, Sharp NA, Bussell JN, Swallow DM, Schwarze J, Guy B, Almond JW, Jeffery PK, Lloyd CM, Papi A, Killington RA, Rowlands DJ, Blair ED, Clarke NJ, Johnston SL.

Nat Med. 2008 Feb;14(2):199-204. doi: 10.1038/nm1713. Epub 2008 Feb 3.

7.

Towards a dengue vaccine: progress to date and remaining challenges.

Guy B, Almond JW.

Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):239-52. Epub 2007 Sep 21. Review.

PMID:
17889365
8.

Vaccine renaissance.

Almond JW.

Nat Rev Microbiol. 2007 Jul;5(7):478-81.

PMID:
17571456
9.

Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.

Macadam AJ, Ferguson G, Stone DM, Meredith J, Knowlson S, Auda G, Almond JW, Minor PD.

J Virol. 2006 Sep;80(17):8653-63.

10.

Serum IgG mediates mucosal immunity against rotavirus infection.

Westerman LE, McClure HM, Jiang B, Almond JW, Glass RI.

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7268-73. Epub 2005 May 9.

11.

Live-attenuated strains of improved genetic stability.

Macadam AJ, Ferguson G, Stone DM, Meredith J, Almond JW, Minor PD.

Dev Biol (Basel). 2001;105:179-87. Review.

PMID:
11763326
12.

Identification of a cis-acting replication element within the poliovirus coding region.

Goodfellow I, Chaudhry Y, Richardson A, Meredith J, Almond JW, Barclay W, Evans DJ.

J Virol. 2000 May;74(10):4590-600.

13.

Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59.

Goodfellow IG, Powell RM, Ward T, Spiller OB, Almond JW, Evans DJ.

J Gen Virol. 2000 May;81(Pt 5):1393-401.

PMID:
10769083
14.

Fatty acid-depleted albumin induces the formation of echovirus A particles.

Ward T, Powell RM, Chaudhry Y, Meredith J, Almond JW, Kraus W, Nelsen-Salz B, Eggers HJ, Evans DJ.

J Virol. 2000 Apr;74(7):3410-2.

15.

Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.

Spiller OB, Goodfellow IG, Evans DJ, Almond JW, Morgan BP.

J Infect Dis. 2000 Jan;181(1):340-3.

PMID:
10608785
16.
17.
18.

Bovine spongiform encephalopathy and new variant Creutzfeldt-Jakob disease.

Almond JW.

Br Med Bull. 1998;54(3):749-59. Review.

PMID:
10326298
19.

Serum albumin inhibits echovirus 7 uncoating.

Ward T, Powell RM, Evans DJ, Almond JW.

J Gen Virol. 1999 Feb;80 ( Pt 2):283-90.

PMID:
10073686
20.

Encapsidation studies of poliovirus subgenomic replicons.

Barclay W, Li Q, Hutchinson G, Moon D, Richardson A, Percy N, Almond JW, Evans DJ.

J Gen Virol. 1998 Jul;79 ( Pt 7):1725-34.

PMID:
9680136
21.

Binding of a cellular factor to the 3' untranslated region of the RNA genomes of entero- and rhinoviruses plays a role in virus replication.

Mellits KH, Meredith JM, Rohll JB, Evans DJ, Almond JW.

J Gen Virol. 1998 Jul;79 ( Pt 7):1715-23.

PMID:
9680135
22.

Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.

Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW.

J Gen Virol. 1998 Jul;79 ( Pt 7):1707-13.

PMID:
9680134
23.

Role for beta2-microglobulin in echovirus infection of rhabdomyosarcoma cells.

Ward T, Powell RM, Pipkin PA, Evans DJ, Minor PD, Almond JW.

J Virol. 1998 Jul;72(7):5360-5.

24.

Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis.

Evans DJ, Almond JW.

Trends Microbiol. 1998 May;6(5):198-202. Review.

PMID:
9614344
25.

Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

Powell RM, Ward T, Evans DJ, Almond JW.

J Virol. 1997 Dec;71(12):9306-12. Erratum in: J Virol 1998 Jan;72(1):890.

26.
27.

Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.

McGoldrick A, Macadam AJ, Dunn G, Rowe A, Burlison J, Minor PD, Meredith J, Evans DJ, Almond JW.

J Virol. 1995 Dec;69(12):7601-5.

28.

Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection?

Almond JW, Brown P, Gore SM, Hofman A, Wientjens PW, Ridley RM, Baker HF, Roberts GW, Tyler KL.

BMJ. 1995 Nov 25;311(7017):1415-21. Review. No abstract available.

29.

Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.

Clarkson NA, Kaufman R, Lublin DM, Ward T, Pipkin PA, Minor PD, Evans DJ, Almond JW.

J Virol. 1995 Sep;69(9):5497-501.

30.

Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.

Whelan SP, Evans D, Almond JW.

Dev Biol Stand. 1995;84:129-36. No abstract available.

PMID:
7796945
31.

The 5' noncoding region and virulence of poliovirus vaccine strains.

Macadam AJ, Stone DM, Almond JW, Minor PD.

Trends Microbiol. 1994 Nov;2(11):449-54. Review.

PMID:
7866703
32.

Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method.

Ward T, Pipkin PA, Clarkson NA, Stone DM, Minor PD, Almond JW.

EMBO J. 1994 Nov 1;13(21):5070-4.

33.
34.

Complete nucleotide sequence of a beta-cell tropic variant of coxsackievirus B4.

Titchener PA, Jenkins O, Szopa TM, Taylor KW, Almond JW.

J Med Virol. 1994 Apr;42(4):369-73.

PMID:
8046427
35.

Role for poliovirus protease 2A in cap independent translation.

Macadam AJ, Ferguson G, Fleming T, Stone DM, Almond JW, Minor PD.

EMBO J. 1994 Feb 15;13(4):924-7.

36.

Transient expression of tagged prion protein (PrP) in a neuronal cell line.

Wightman LM, Poidinger M, Almond JW.

Gene Ther. 1994;1 Suppl 1:S66. No abstract available.

PMID:
8542412
37.

Genetic basis of attenuation of the Sabin oral poliovirus vaccines.

Minor PD, Macadam AJ, Stone DM, Almond JW.

Biologicals. 1993 Dec;21(4):357-63. Review. No abstract available.

PMID:
8024751
38.

The remaining stocks of smallpox virus should be destroyed.

Mahy BW, Almond JW, Berns KI, Chanock RM, Lvov DK, Pettersson RF, Schatzmayr HG, Fenner F.

Science. 1993 Nov 19;262(5137):1223-4. No abstract available.

PMID:
8235651
40.

Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.

Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, Minor PD.

Virology. 1993 Jan;192(1):18-26.

PMID:
8390752
41.

Approaches to the construction of new candidate poliovirus type 3 vaccine strains.

Almond JW, Stone D, Burke K, Skinner MA, Macadam AJ, Wood D, Ferguson M, Minor PD.

Dev Biol Stand. 1993;78:161-9; discussion 169-70. Review.

PMID:
8388827
42.

Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture.

Macadam AJ, Ferguson G, Burlison J, Stone D, Skuce R, Almond JW, Minor PD.

Virology. 1992 Aug;189(2):415-22.

PMID:
1641974
44.

Radiation-reduced hybrids for the myotonic dystrophy locus.

Brook JD, Zemelman BV, Hadingham K, Siciliano MJ, Crow S, Harley HG, Rundle SA, Buxton J, Johnson K, Almond JW, et al.

Genomics. 1992 Jun;13(2):243-50.

PMID:
1612584
45.

Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site.

McKeating JA, Moore JP, Ferguson M, Marsden HS, Graham S, Almond JW, Evans DJ, Weiss RA.

AIDS Res Hum Retroviruses. 1992 Apr;8(4):451-9.

PMID:
1376134
47.

Design and construction of poliovirus epitope expression vectors.

Burke KL, Almond JW, Evans DJ.

Methods Mol Biol. 1992;8:249-56. doi: 10.1385/0-89603-191-8:249.

PMID:
21390717
48.

Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4.

Minor PD, Ferguson M, Katrak K, Wood D, John A, Howlett J, Dunn G, Burke K, Almond JW.

J Gen Virol. 1991 Oct;72 ( Pt 10):2475-81.

PMID:
1717641
50.

The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity.

Macadam AJ, Pollard SR, Ferguson G, Dunn G, Skuce R, Almond JW, Minor PD.

Virology. 1991 Apr;181(2):451-8.

PMID:
1707566

Supplemental Content

Loading ...
Support Center